A-Cell: Generation of QTPP, Risk Assessment and Critical Quality Attribute Identification

This webinar will cover the elements of Quality by Design for cell-based therapies, including the QTPP as a product development and life cycle management tool, and risk assessment approaches to identify product CQAs and critical process parameters (CPPs). The speaker will then explain how developing a good understanding of the inter-relationships between CPPs, CQAs and clinical outcomes is fundamental to the implementation of an effective control strategy, leading to greater assurance of product quality.
Speaker:
Pinar Cicalese, Ph.D., Director CMC Commercial Strategy, Immatics